Data by

Celgene

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Celgene's 2013 oncology sales performance.

BMS appoints Saurabh Saha as senior VP, global head of translational medicine

chief executive officer of Delinia until its sale to Celgene.

Finalists 2017

with support from Oi Ltd. Progression Free Living. by Celgene. QUINSAIR – Awaken the Lungs. ... with support from Oi Ltd. Collaboration: Creating Value Together. by Celgene.

Novartis gets EU nod for leukaemia drug Rydapt

or AML with myelodysplasia-related changes (AML-MRC) – while Celgene/Agios claimed approval for Idhifa (enasidenib) as a treatment for AML patients with the IDH2 mutation.

Teva poaches Lundbeck's Schultz as new CEO

AstraZeneca CEO Pascal Soriot and Celgene's chief operating officer Jacqualyn Fouse have both been linked with the job in the interim.

BMS' Opdivo and Yervoy ace kidney cancer trial

The FDA is concerned about the risk associated with combining PD-1/PD-L1 inhibitors such as Keytruda and Opdivo with Celgene's Pomalyst (pomalidomide) or Revlimid (lenalidomide), two widely-used

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 5)

Oncology revenue 2014
1: Roche
2: Novartis
3: Celgene
4: Johnson & Johnson
5: Bristol-Myers Squibb
6: Lilly
7: Takeda
8: AstraZeneca
9: Merck & Co.
10: Amgen
11: Pfizer
12: Astellas
13: Bayer
14: Otsuka
15: Sanofi
16: Merck KGaA
17: Eisai
18: AbbVie
19: Pharmacyclics
20: Incyte

Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Account Director at PAREXEL MedCom: Competitive Salary

Medical Editor: Great salary and benefits

Senior Account Executive – Medical Education – Global Agency: Salary TBC

Account Director, Healthcare Communications: £50, 000 - £60, 000

Principal Medical Writer, Medical Communications, London.: Competitive

Principal Medical Writer: Great salary and benefits

Head of Art/ Creative Director: Neg

Account Director: Salary TBC

Editorial Director - BioScience: Competitive Salary

Market Access Writer (Various Levels) – Hampshire/ Home Working...: Negotiable

AM – Healthcare Comms/ Marketing – North East: Negotiable

Associate Project Director – Medical Communications: Salary TBC

Scientific Team Leader, Medical Education: £55, 000 – £70, 000 benefits

Digital Account Director – Healthcare Communications: £50 – 60, 000 benefits

Managing Director – Healthcare Market Research: Neg

Scientific Director, Medical Communications: £60 – 70, 000 benefits

Global Planning Partner – Global Healthcare Comms Agency: Salary TBC

How Can We Make Payer Communications Really Sing?: With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access: This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...
So how do you really engage with patients?: The most valuable insights from patient engagement are the most unexpected ones. Simple things, which may seem unimportant to you, may be the key to making patients’ lives easier and...